Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Read more
Sign In
June 18, 20214:35 AM PDTLast Updated a month ago
Asia Pacific
Taiwan to allow Foxconn's Gou, TSMC to negotiate for vaccines
Yimou LeeBen Blanchard

3 minute read
Foxconn Technology Group founder and chairman, Terry Gou, speaks during a news conference after his trip to the U.S., in Taipei, Taiwan May 6, 2019. REUTERS/Tyrone Siu
TAIPEI, June 18 (Reuters) - Taiwan will allow Terry Gou, the billionaire founder of Taiwan's Foxconn (2317.TW), and TSMC (2330.TW) to negotiate on its behalf for COVID-19 vaccines, a government spokesman said on Friday, but warned there was no guarantee of success.
Taiwan is trying to speed up the arrival of the millions of vaccines it has on order as it deals with a rise in domestic cases, although infections remain comparatively low. Only around 6% of Taiwan's 23.5 million people have received at least one of the two-shot coronavirus vaccine regimen.
The government has come under pressure to allow private firms to buy vaccines, and said while it welcomes the idea and is willing to help, they have to provide proof from vaccine producers they have shots and are willing to sell them.
Speaking to reporters after Gou said he was seeking a meeting with President Tsai Ing-wen to discuss his plans to buy 5 million shots from Germany's BioNTech SE (22UAy.DE), Cabinet spokesman Lo Ping-cheng said Taiwan Semiconductor Manufacturing Co Ltd (TSMC) (2330.TW) wanted to donate an equal amount.
Lo said BioNTech had told Gou, who wants to make the purchase through his Yonglin Education Foundation, on Wednesday they will only sell vaccines to governments.
"A good method is for the government to, under this framework, authorise TSMC and the Yonglin Education Foundation to buy them and then donate to the government," he said.
He said the government was, with the help of the German government, continuing its own talks with BioNTech, adding there was no guarantee Gou or anyone else would succeed.
"Even if Mr. Gou can discuss this with the original manufacturer or an agent, can he get them to sell sufficient vaccines? Honestly, nobody knows."
TSMC said it "confirmed the initiative", but offered no other details. BioNTech declined to comment.
Presidential office spokesman Xavier Chang said Tsai had met Gou and TSMC Chairman Mark Liu on Friday to discuss their proposals in a "good and friendly" atmosphere.
"We all hope that it is produced in the original factory with the original packaging and will be delivered directly to Taiwan," he said, referring to the BioNTech shots.
Gou's spokesperson Amanda Liu said after the meeting that a "consensus was reached on key issues", and quoted Gou as saying "It's a daunting mission and there's a long way to go and we will do our best!"
Taiwan's own deal with BioNTech fell through this year, with the government blaming it on pressure from Beijing.
China has denied the accusation, saying Taiwan is free to obtain the vaccines through Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS), which has a contract with BioNTech to sell the vaccines in China, Hong Kong, Macau and Taiwan.
Taiwan has been dealing directly with BioNTech in Germany, saying it does not trust vaccines from China.
Shieh Jhy-wey, Taiwan's de facto ambassador in Berlin, said that Germany's Economy Ministry had appointed officials to talk directly with BioNTech, adding the company had told him they were willing to sell vaccines to Taiwan directly from Europe.
Germany's Economy Ministry declined to comment.
Japan donated 1.24 million AstraZeneca Plc (AZN.L) shots to Taiwan this month and the United States has pledged 750,000 doses, although it has not given details, all on top of vaccines Taiwan has already ordered.
Another 240,000 Moderna Inc (MRNA.O) doses arrived in Taiwan later on Friday.
Reporting by Ben Blanchard and Yimou Lee; Editing by Raju Gopalakrishnan
Our Standards: The Thomson Reuters Trust Principles.
More from Reuters
Play video on original page
Read Next
Asia Pacific
U.S offers further air support to Afghan troops amid Taliban offensive
12:18 PM PDT
China's TAL Education expects hit from new private tutoring rules
9:36 AM PDT
Asia Pacific
Two activists killed in tightly fought vote in Pakistan's Kashmir
8:47 AM PDT
Asia Pacific
Asian COVID epicentre of Indonesia extends curbs by a week
8:36 AM PDT

Sign up for our newsletter
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Asia Pacific
Asia Pacific · 8:36 AM PDT
Asian COVID epicentre of Indonesia extends curbs by a week
Indonesia extended its COVID-19 restrictions by a week to Aug. 2 on Sunday to try to curb infections, after the government said it would add more intensive care units amid a rise in deaths.
Asia Pacific
Australians may face longer lockdown after "reckless" mass protests
3:41 AM PDT
Asia Pacific
First task for Afghan forces is to slow Taliban's momentum -Pentagon chief
July 24, 2021
Asia Pacific
South Korea steps up COVID-19 curbs ahead of peak holiday season
3:19 AM PDT
Asia Pacific
U.S offers further air support to Afghan troops amid Taliban offensive
11:52 AM PDT
About Reuters
About Reuters
Reuters News Agency
Brand Attribution Guidelines
Reuters Leadership
Reuters Fact Check
Reuters Diversity Report
Stay Informed
Download the App
Information you can trust
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Follow Us
Thomson Reuters Products
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Refinitiv Products
Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface.
Refinitiv Data Platform
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
Advertise With Us
Advertising Guidelines
Terms of Use
Site Feedback

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved